文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

严重急性肾损伤延迟与早期启动肾脏替代治疗:随机临床试验的系统评价与个体患者数据荟萃分析

Delayed versus early initiation of renal replacement therapy for severe acute kidney injury: a systematic review and individual patient data meta-analysis of randomised clinical trials.
PubMed 文献 · Lancet · 2020-04-23
一句话结论在无紧急RRT指征的严重AKI危重患者中,延迟与早期启动RRT的28天死亡率无显著差异,延迟策略可能减少RRT使用。

该研究为系统评价与个体患者数据荟萃分析,纳入10项随机试验(含2143例患者),其中9项试验的2083例患者有个体数据,1879例严重AKI患者被随机分配至延迟RRT组(946例)或早期RRT组(933例)。主要终点28天全因死亡率在延迟组为44%(366/837),早期组为43%(355/827),风险比1.01(95%CI 0.91-1.13,P=0.80),无显著差异,研究间异质性I²=0%。延迟组中42%(390/929)未接受RRT。作者认为,在无紧急RRT指征时,延迟启动RRT不影响生存,且可能减少RRT使用、节约医疗资源。

要点

  • 在无紧急RRT指征的严重AKI危重成人中,延迟与早期启动RRT的28天全因死亡率无显著差异(44% vs 43%,RR 1.01,95%CI 0.91-1.13,P=0.80)。
  • 延迟RRT组中42%(390/929)的患者未接受RRT,提示延迟策略可能减少RRT使用。
  • 研究间异质性低(I²=0%),多数研究偏倚风险低。
  • 作者认为,在无紧急指征时延迟启动RRT并密切监测患者,可能减少RRT使用并节约医疗资源。

适用人群与场景

  • 纳入标准:危重患者,年龄18岁或以上,急性肾损伤定义为KDIGO AKI分期2期或3期,或在KDIGO不可用时肾脏序贯器官衰竭评估评分3分或以上。
  • 排除标准:无急性肾损伤或未被随机分配的患者不纳入个体患者数据荟萃分析。

诊断标准与关键阈值

  • 急性肾损伤定义:KDIGO AKI分期2期或3期,或在KDIGO不可用时肾脏序贯器官衰竭评估评分3分或以上。

研究设计与关键结果

  • 研究类型:系统评价与个体患者数据荟萃分析,纳入10项随机试验(含2143例患者),其中9项试验(2083例患者)有个体患者数据,1879例严重AKI患者被随机分配:延迟RRT组946例(50%),早期RRT组933例(50%)。
  • 主要终点:28天全因死亡率,延迟RRT组44%(366/837)vs 早期RRT组43%(355/827),风险比1.01(95%CI 0.91-1.13),P=0.80,风险差0.01(95%CI -0.04至0.06)。
  • 延迟RRT组中42%(390/929)有可用数据的患者未接受RRT。
  • 研究间异质性:I²=0%,τ²=0;多数研究偏倚风险低。

证据类型、等级与局限

  • 证据类型:系统评价与个体患者数据荟萃分析,纳入随机临床试验。
  • 研究间无显著异质性(I²=0%,τ²=0),多数研究偏倚风险低。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在无紧急RRT指征的严重AKI危重患者中,延迟启动RRT不影响28天生存,作者认为延迟启动并密切监测患者可能减少RRT使用并节约医疗资源。
  • 延迟RRT组中42%的患者未接受RRT,提示部分患者可避免RRT。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The timing of renal replacement therapy (RRT) for severe acute kidney injury is highly debated when no life-threatening complications are present. We assessed whether a strategy of delayed versus early RRT initiation affects 28-day survival in critically ill adults with severe acute kidney injury.

METHODS: In this systematic review and individual patient data meta-analysis, we searched MEDLINE (via PubMed), Embase, and the Cochrane Central Register of Controlled Trials for randomised trials published from April 1, 2008, to Dec 20, 2019, that compared delayed and early RRT initiation strategies in patients with severe acute kidney injury. Trials were eligible for inclusion if they included critically ill patients aged 18 years or older with acute kidney injury (defined as a Kidney Disease: Improving Global Outcomes [KDIGO] acute kidney injury stage 2 or 3, or, where KDIGO was unavailable, a renal Sequential Organ Failure Assessment score of 3 or higher). We contacted the principal investigator of each eligible trial to request individual patient data. From the included trials, any patients without acute kidney injury or who were not randomly allocated were not included in the individual patient data meta-analysis. The primary outcome was all-cause mortality at day 28 after randomisation. This study is registered with PROSPERO (CRD42019125025).

FINDINGS: Among the 1031 studies identified, one study that met the eligibility criteria was excluded because the recruitment period was not recent enough, and ten (including 2143 patients) were included in the analysis. Individual patient data were available for nine studies (2083 patients), from which 1879 patients had severe acute kidney injury and were randomly allocated: 946 (50%) to the delayed RRT group and 933 (50%) to the early RRT group. 390 (42%) of 929 patients allocated to the delayed RRT group and who had available data did not receive RRT. The proportion of patients who died by day 28 did not significantly differ between the delayed RRT group (366 [44%] of 837) and the early RRT group (355 [43%] of 827; risk ratio 1·01 [95% CI 0·91 to 1·13], p=0·80), corresponding to an overall risk difference of 0·01 (95% CI -0·04 to 0·06). There was no heterogeneity across studies (I2=0%; τ2=0), and most studies had a low risk of bias.

INTERPRETATION: The timing of RRT initiation does not affect survival in critically ill patients with severe acute kidney injury in the absence of urgent indications for RRT. Delaying RRT initiation, with close patient monitoring, might lead to a reduced use of RRT, thereby saving health resources.

来源:Lancet,查看原文。版权归原作者所有。

参考来源

  1. Gaudry S, Hajage D, Benichou N, et al. Delayed versus early initiation of renal replacement therapy for severe acute kidney injury: a systematic review and individual patient data meta-analysis of randomised clinical trials. Lancet. 2020. PMID: 32334654. doi:10.1016/S0140-6736(20)30531-6

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。